FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas

Παρόμοια τεκμήρια

• FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures
  ανά: Wong, K, κ.ά.
  Έκδοση: (2016)
• The significance of FOXP1 in diffuse large B-cell lymphoma
  ανά: Gascoyne, D, κ.ά.
  Έκδοση: (2016)
• Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
  ανά: Wong, K, κ.ά.
  Έκδοση: (2014)
• Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients.
  ανά: Wong, K, κ.ά.
  Έκδοση: (2014)
• N-terminally truncated FOXP1 protein expression and alternate internal FOXP1 promoter usage in normal and malignant B cells.
  ανά: Brown, P, κ.ά.
  Έκδοση: (2016)